Researchers Examine the Potential Misuse of Anti-anxiety Medication
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create. A new British Journal of Clinical Pharmacology study found that non-medical use of alprazolam in the United Kingdom is a significant issue, and it appears to be more prevalent in younger adults.
The study examined results from a survey that included 10,019 adults in the United Kingdom. The estimated national prevalence of lifetime non-medical use of alprazolam was 0.32%, and 1.30% for diazepam (valium), another anti-anxiety medication. The prevalence of non-medical use in the last 90 days was significantly different when split by age category for alprazolam, but not for diazepam, with alprazolam non-medical use being more common among younger adults.
The authors noted that most individuals taking alprazolam for non-medical reasons are doing so without a prescription and therefore are unlikely to obtain medical advice before use.
"Further research is urgently needed to further explore the motivations for and appeal of alprazolam for non-medical use among young adults," they wrote. "This will enable appropriate public health interventions to prevent short-term toxicity and long-term dependence among young adults who are regularly using alprazolam."
Reference: Joanna Hockenhull, et al. Non‐medical use of alprazolam in the United Kingdom: results from a nationally representative survey. BJCP (2019) DOI: https://doi.org/10.1111/bcp.13959
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.READ MORE
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.